High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study

Aims/hypothesisLarge clinical studies describing the typical clinical presentation of diabetic foot ulcers are limited and most studies were performed in single centres with the possibility of selection of specific subgroups. The aim of this study was to investigate the characteristics of diabetic patients with a foot ulcer in 14 European hospitals in ten countries.MethodsThe study population included 1,229 consecutive patients presenting with a new foot ulcer between 1 September 2003 and 1 October 2004. Standardised data on patient characteristics, as well as foot and ulcer characteristics, were obtained. Foot disease was categorised into four stages according to the presence or absence of peripheral arterial disease (PAD) and infection: A: PAD −, infection −; B: PAD −, infection +; C: PAD +, infection −; D: PAD +, infection +.ResultsPAD was diagnosed in 49% of the subjects, infection in 58%. The majority of ulcers (52%) were located on the non-plantar surface of the foot. With regard to severity, 24% had stage A, 27% had stage B, 18% had stage C and 31% had stage D foot disease. Patients in the latter group had a distinct profile: they were older, had more non-plantar ulcers, greater tissue loss and more serious comorbidity.Conclusions/interpretationAccording to our results in this European cohort, the severity of diabetic foot ulcers at presentation is greater than previously reported, as one-third had both PAD and infection. Non-plantar foot ulcers were more common than plantar ulcers, especially in patients with severe disease, and serious comorbidity increased significantly with increasing severity of foot disease. Further research is needed to obtain insight into the clinical outcome of these patients.

[1]  Anthony Delitto,et al.  Total Contact Casting in Treatment of Diabetic Plantar Ulcers: Controlled Clinical Trial , 1989, Diabetes Care.

[2]  T. Deckert,et al.  Limb salvage in diabetics with foot ulcers , 1989, Prosthetics and orthotics international.

[3]  C. Agardh,et al.  The Importance of Peripheral Pulses, Peripheral Oedema and Local Pain for the Outcome of Diabetic Foot Ulcers , 1990, Diabetic medicine : a journal of the British Diabetic Association.

[4]  C. Agardh,et al.  The association between clinical risk factors and outcome of diabetic foot ulcers. , 1992, Diabetes research and clinical practice.

[5]  D. Smith,et al.  Predictors of Transcutaneous Oxygen Tension in the Lower Limbs of Diabetic Subjects , 1996, Diabetic medicine : a journal of the British Diabetic Association.

[6]  F. Vinicor,et al.  Independent Physiological Predictors of Foot Lesions in Patients With NIDDM , 1997, Diabetes Care.

[7]  David G Armstrong,et al.  Validation of a Diabetic Wound Classification System: The contribution of depth, infection, and ischemia to risk of amputation , 1998, Diabetes Care.

[8]  G. Reiber,et al.  The burden of diabetic foot ulcers. , 1998, American journal of surgery.

[9]  F. Gries,et al.  Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[10]  D G Smith,et al.  Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. , 1999, Diabetes care.

[11]  E H Wagner,et al.  Incidence, outcomes, and cost of foot ulcers in patients with diabetes. , 1999, Diabetes care.

[12]  R. Rutherford,et al.  Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). , 2000, Journal of vascular surgery.

[13]  Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC). , 2000, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[14]  A. Whittemore Presidential address: a team for the 21st century: the vascular center. , 2000, Journal of vascular surgery.

[15]  I Tarawneh,et al.  The effects of ulcer size and site, patient's age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers , 2001, Diabetic medicine : a journal of the British Diabetic Association.

[16]  D. Armstrong,et al.  Off-loading the diabetic foot wound: a randomized clinical trial. , 2001, Diabetes care.

[17]  N. Schaper,et al.  The effect of diabetes and severe ischaemia on the penetration of ceftazidime into tissues of the limb , 2001, Diabetic Medicine.

[18]  I Tarawneh,et al.  A comparison of two diabetic foot ulcer classification systems: the Wagner and the University of Texas wound classification systems. , 2001, Diabetes care.

[19]  Jesse A Berlin,et al.  Diabetic neuropathic foot ulcers: the association of wound size, wound duration, and wound grade on healing. , 2002, Diabetes care.

[20]  N. Schaper,et al.  The Diabetic Foot: Pathogenesis and Clinical Evaluation , 2002, Seminars in Vascular Medicine.

[21]  J. Griffiths,et al.  The North‐West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community‐based patient cohort , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[22]  W. Jeffcoate,et al.  Diabetic foot ulcers , 2003, The Lancet.

[23]  R. Frykberg An evidence-based approach to diabetic foot infections. , 2003, American journal of surgery.

[24]  G. Gill,et al.  Amputation and Mortality in New-Onset Diabetic Foot Ulcers Stratified by Etiology , 2003 .

[25]  David G Armstrong,et al.  Predictive value of foot pressure assessment as part of a population-based diabetes disease management program. , 2003, Diabetes care.

[26]  P. Fratino,et al.  HYAFF 11-based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial. , 2003, Diabetes care.

[27]  Michael J. Mueller,et al.  Effect of Achilles tendon lengthening on neuropathic plantar ulcers. A randomized clinical trial. , 2003, The Journal of bone and joint surgery. American volume.

[28]  Vijay Viswanathan,et al.  Effectiveness of different types of footwear insoles for the diabetic neuropathic foot: a follow-up study. , 2004, Diabetes care.

[29]  J. Apelqvist,et al.  Health-economic consequences of diabetic foot lesions. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  N. Schaper,et al.  Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies , 2004, Diabetes/Metabolism Research Reviews.

[31]  A. Boulton The diabetic foot: from art to science. The 18th Camillo Golgi lecture , 2004, Diabetologia.

[32]  L. Harkless,et al.  An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers. , 2005, Surgical infections.

[33]  Georgeanne Botek,et al.  Treatment for diabetic foot ulcers , 2005, The Lancet.

[34]  D. Armstrong,et al.  Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial , 2005, The Lancet.

[35]  M. Huijberts,et al.  Total contact casting of the diabetic foot in daily practice: a prospective follow-up study. , 2005, Diabetes care.

[36]  A. Morabito,et al.  Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. , 2005, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[37]  G. Gardiner Bypass Versus Angioplasty in Severe Ischaemia of the Leg (BASIL): Multicentre, Randomised Controlled Trial , 2006 .